BTTUJVRWRKISPI-FQEVSTJZSA-N
C27H32F6N6O5S — CID 146217742
Data last refreshed: (MolForge compound catalog, from PubChem)
About BTTUJVRWRKISPI-FQEVSTJZSA-N
BTTUJVRWRKISPI-FQEVSTJZSA-N (PubChem CID 146217742) has the molecular formula C27H32F6N6O5S and a molecular weight of 666.65 g/mol. Its IUPAC name is [3-[1-[2-(trifluoromethyl)-6-[(2S)-2-[2-[4-(trifluoromethyl)phenyl]ethylcarbamoyl]azetidin-1-yl]pyrimidin-4-yl]piperidin-4-yl]propanoylamino]methanesulfonic acid.
Molecular Properties
| Compound Name | BTTUJVRWRKISPI-FQEVSTJZSA-N |
|---|---|
| PubChem CID | 146217742 |
| Molecular Formula | C27H32F6N6O5S |
| Molecular Weight | 666.65 g/mol |
| Exact Mass | 666.21 |
| IUPAC Name | [3-[1-[2-(trifluoromethyl)-6-[(2S)-2-[2-[4-(trifluoromethyl)phenyl]ethylcarbamoyl]azetidin-1-yl]pyrimidin-4-yl]piperidin-4-yl]propanoylamino]methanesulfonic acid |
| SMILES | O=C(CCC1CCN(c2cc(N3CC[C@H]3C(=O)NCCc3ccc(C(F)(F)F)cc3)nc(C(F)(F)F)n2)CC1)NCS(=O)(=O)O |
| InChI | InChI=1S/C27H32F6N6O5S/c28-26(29,30)19-4-1-17(2-5-19)7-11-34-24(41)20-10-14-39(20)22-15-21(36-25(37-22)27(31,32)33)38-12-8-18(9-13-38)3-6-23(40)35-16-45(42,43)44/h1-2,4-5,15,18,20H,3,6-14,16H2,(H,34,41)(H,35,40)(H,42,43,44)/t20-/m0/s1 |
| InChIKey | BTTUJVRWRKISPI-FQEVSTJZSA-N |
| XLogP | 3.41 |
| TPSA | 144.83 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 666.65 |
| LogP ≤ 5 | 3.41 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146217742 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.